Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study.

Ito, Daisuke; Ikuma-Suwa, Emi; Inoue, Kazuyuki; Kaneko, Kimie; Yanagisawa, Morifumi; Inukai, Kouichi; Noda, Mitsuhiko; Shimada, Akira

Ito, Daisuke; Ikuma-Suwa, Emi; Inoue, Kazuyuki; Kaneko, Kimie; Yanagisawa, Morifumi; Inukai, Kouichi; Noda, Mitsuhiko; Shimada, Akira.

Afiliación

Ito D; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan; Department of Internal Medicine, Ogawa Red Cross Hospital, Saitama, Japan.
Ikuma-Suwa E; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
Inoue K; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan; Department of Internal Medicine, Ogawa Red Cross Hospital, Saitama, Japan.
Kaneko K; Department of Nursing, Ogawa Red Cross Hospital, Saitama, Japan.
Yanagisawa M; Department of Internal Medicine, Ogawa Red Cross Hospital, Saitama, Japan; Satsuki Medical Clinic, Saitama, Japan.
Inukai K; Department of Diabetes and Endocrinology, Higashiyamato Hospital, Tokyo, Japan.
Noda M; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
Shimada A; Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.

J Clin Med Res ; 9(2): 154-162, 2017 Feb.

Article en En | MEDLINE | ID: mdl-28090231

Palabras clave

Blood pressure; Diabetic nephropathy; Ipragliflozin; Sodium-glucose cotransporter 2 inhibitor; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Med Res Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google